Taiwan FDA registration e9620edbbfb69767b20f8221777778e2
Microferk 2 gram-negative bacteria drug Minka antibiotic-β-lactam combination
TW: 微鐵克2革蘭氏陰性菌藥敏卡抗生素-β-內醯胺類組合類
Taiwan·Risk Class 2·bioMérieux, Inc.·Registered Mar 13, 2020 – Mar 13, 2025ExpiredRegistration details
- Analysis ID
- e9620edbbfb69767b20f8221777778e2
- Customs Code
- DHA05603328900
Company information
- Manufacturer
- bioMérieux, Inc.
- Manufacturer Country
- United States
- Authorized Representative
- BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG)
Product details
- Intended Use
- This product can be used with Microtek 2 automatic microbial analyzer to measure antibiotic susceptibility in clinical laboratories for clinically important aerobic gram-negative bacilli in vitro.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1640 抗菌感受性試驗粉末
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Mar 13, 2020
- Expiry Date
- Mar 13, 2025
About this record
Access comprehensive regulatory information for Microferk 2 gram-negative bacteria drug Minka antibiotic-β-lactam combination in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e9620edbbfb69767b20f8221777778e2 and manufactured by bioMérieux, Inc.. The authorized representative in Taiwan is BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices